MAZE
NASDAQ · Pharmaceuticals
Maze Therapeutics Inc
$25.68
+0.84 (+3.38%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-39.00%
1Y
+148.60%
YTD
-35.43%
Open$25.51
Previous Close$24.84
Day High$25.84
Day Low$24.96
52W High$53.65
52W Low$9.83
Volume—
Avg Volume659.4K
Market Cap1.42B
P/E Ratio—
EPS$-2.52
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$42.71
Below
SMA 200
$25.83
Below
RSI (14)
50.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+265.7% upside
Current
$25.68
$25.68
Target
$93.90
$93.90
$74.59
$93.90 avg
$145.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 190.13M | 546.10M | 525.77M |
| Net Income | 20.86M | 109.70M | 88.79M |
| Profit Margin | 11.0% | 20.1% | 16.9% |
| EBITDA | 69.11M | 173.82M | 160.69M |
| Free Cash Flow | — | 65.89M | 67.30M |
| Rev Growth | — | +21.9% | +7.3% |
| Debt/Equity | — | 0.74 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |